The Pennant Group (PNTG) Competitors $25.22 -0.36 (-1.41%) Closing price 04:00 PM EasternExtended Trading$25.21 -0.01 (-0.04%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PNTG vs. CON, SGRY, PRVA, VCYT, HTFL, CELC, LFST, ADUS, PGNY, and ARDTShould you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Veracyte (VCYT), Heartflow (HTFL), Celcuity (CELC), LifeStance Health Group (LFST), Addus HomeCare (ADUS), Progyny (PGNY), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry. The Pennant Group vs. Its Competitors Concentra Group Holdings Parent Surgery Partners Privia Health Group Veracyte Heartflow Celcuity LifeStance Health Group Addus HomeCare Progyny Ardent Health The Pennant Group (NASDAQ:PNTG) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk. Which has stronger earnings & valuation, PNTG or CON? Concentra Group Holdings Parent has higher revenue and earnings than The Pennant Group. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Pennant Group$695.24M1.25$22.56M$0.7832.33Concentra Group Holdings Parent$2.01B1.36$166.54M$1.1917.87 Do insiders & institutionals believe in PNTG or CON? 85.9% of The Pennant Group shares are owned by institutional investors. 5.4% of The Pennant Group shares are owned by insiders. Comparatively, 6.6% of Concentra Group Holdings Parent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is PNTG or CON more profitable? Concentra Group Holdings Parent has a net margin of 7.44% compared to The Pennant Group's net margin of 3.36%. Concentra Group Holdings Parent's return on equity of 50.84% beat The Pennant Group's return on equity.Company Net Margins Return on Equity Return on Assets The Pennant Group3.36% 9.85% 4.04% Concentra Group Holdings Parent 7.44%50.84%5.89% Which has more volatility and risk, PNTG or CON? The Pennant Group has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, Concentra Group Holdings Parent has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. Does the media refer more to PNTG or CON? In the previous week, The Pennant Group and The Pennant Group both had 4 articles in the media. Concentra Group Holdings Parent's average media sentiment score of 1.67 beat The Pennant Group's score of 1.13 indicating that Concentra Group Holdings Parent is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Concentra Group Holdings Parent 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts rate PNTG or CON? The Pennant Group presently has a consensus target price of $34.40, indicating a potential upside of 36.40%. Concentra Group Holdings Parent has a consensus target price of $27.50, indicating a potential upside of 29.34%. Given The Pennant Group's higher possible upside, equities research analysts plainly believe The Pennant Group is more favorable than Concentra Group Holdings Parent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Pennant Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Concentra Group Holdings Parent 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryConcentra Group Holdings Parent beats The Pennant Group on 11 of the 15 factors compared between the two stocks. Get The Pennant Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PNTG vs. The Competition Export to ExcelMetricThe Pennant GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$871.60M$4.10B$5.75B$10.28BDividend YieldN/A1.28%5.72%4.60%P/E Ratio32.3328.7574.9926.41Price / Sales1.2525.46456.1088.49Price / Cash27.7526.8725.8129.91Price / Book2.784.4813.256.28Net Income$22.56M$189.47M$3.29B$270.38M7 Day Performance2.90%-1.68%0.46%2.69%1 Month Performance-0.16%2.15%4.59%5.98%1 Year Performance-26.94%13.96%73.41%25.93% The Pennant Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PNTGThe Pennant Group4.3578 of 5 stars$25.22-1.4%$34.40+36.4%-25.9%$871.60M$695.24M32.337,000CONConcentra Group Holdings Parent3.0999 of 5 stars$22.79-1.3%$27.50+20.7%-4.0%$2.96B$1.90B19.1511,250Positive NewsSGRYSurgery Partners3.1579 of 5 stars$22.08-1.9%$33.00+49.5%-29.5%$2.89B$3.11B-15.4415,000News CoveragePositive NewsPRVAPrivia Health Group4.4218 of 5 stars$23.59+1.3%$28.58+21.2%+20.3%$2.86B$1.74B214.471,140Positive NewsVCYTVeracyte3.7554 of 5 stars$32.46+0.1%$40.90+26.0%-6.2%$2.55B$445.76M98.37790HTFLHeartflowN/A$34.50+11.0%$35.80+3.8%N/A$2.52BN/A0.00699Quiet Period ExpirationGap UpCELCCelcuity1.2736 of 5 stars$62.53+12.3%$56.50-9.6%+266.6%$2.36BN/A-18.1240Positive NewsLFSTLifeStance Health Group3.5095 of 5 stars$5.61+4.5%$8.50+51.5%-24.6%$2.09B$1.25B-112.2010,218Positive NewsADUSAddus HomeCare4.9909 of 5 stars$114.36+1.0%$138.89+21.4%-15.3%$2.09B$1.15B25.2549,703Positive NewsPGNYProgyny3.8469 of 5 stars$22.85+1.3%$25.30+10.7%-6.8%$1.94B$1.17B38.73310Positive NewsARDTArdent Health3.4982 of 5 stars$13.45+2.2%$19.56+45.4%-28.0%$1.88B$5.97B7.4324,900Positive News Related Companies and Tools Related Companies CON Competitors SGRY Competitors PRVA Competitors VCYT Competitors HTFL Competitors CELC Competitors LFST Competitors ADUS Competitors PGNY Competitors ARDT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PNTG) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Pennant Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share The Pennant Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PNTG Stock Alerts